Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODERATO: Dual Maintenance Therapy vs Standard Triple Therapy in HIV-1
NCT04022967Phase 3Completed
- Sponsor
- ANRS
- Start
- Nov 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of dolutegravir, atazanavir, lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Started Nov 2020; status: completed.
02
Drugs
dolutegraviratazanavirlamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT04022967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04022967.